Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2019, Article ID 9627810, 12 pages
https://doi.org/10.1155/2019/9627810
Research Article

Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway

1Biology Department, College of Science, King Khalid University, Abha, Saudi Arabia
2Zoology Department, College of Science, Damanhour University, Egypt
3Department of Basic Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
4King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

Correspondence should be addressed to Attalla Farag El-kott; moc.oohay@fattokle

Received 9 January 2019; Revised 27 April 2019; Accepted 30 April 2019; Published 8 July 2019

Academic Editor: Consuelo Amantini

Copyright © 2019 Attalla Farag El-kott et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Attalla Farag El-kott, Ali A. Shati, Mohammed Ali Al-kahtani, and Sultan Alqahtani, “Acylated Ghrelin Renders Chemosensitive Ovarian Cancer Cells Resistant to Cisplatin Chemotherapy via Activation of the PI3K/Akt/mTOR Survival Pathway,” Analytical Cellular Pathology, vol. 2019, Article ID 9627810, 12 pages, 2019. https://doi.org/10.1155/2019/9627810.